Monkeypox: What do we know?
- By Dragos-Paul Hagiu,
- Yves Le Noc,
- Marc Dumoulin,
- Gérard Bergua,
- Éric Drahi,
- Claude Scali
- and Élisabeth Steyer
Pages 110 to 113
Cite this article
- HAGIU, Dragos-Paul,
- LE NOC, Yves,
- DUMOULIN, Marc,
- BERGUA, Gérard,
- DRAHI, Éric,
- SCALI, Claude
- and STEYER, Élisabeth,
- Hagiu, Dragos-Paul.,
- et al.
- Hagiu, D.-P.,
- Le Noc, Y.,
- Dumoulin, M.,
- Bergua, G.,
- Drahi, É.,
- Scali, C.
- and Steyer, É.
https://doi.org/10.1684/med.2023.864
Cite this article
- Hagiu, D.-P.,
- Le Noc, Y.,
- Dumoulin, M.,
- Bergua, G.,
- Drahi, É.,
- Scali, C.
- and Steyer, É.
- Hagiu, Dragos-Paul.,
- et al.
- HAGIU, Dragos-Paul,
- LE NOC, Yves,
- DUMOULIN, Marc,
- BERGUA, Gérard,
- DRAHI, Éric,
- SCALI, Claude
- and STEYER, Élisabeth,
https://doi.org/10.1684/med.2023.864
Monkeypox is an infectious disease caused by an orthopoxvirus. It is characterized in particular by a rash occurring within one to three days after an initial non-specific phase. Cases not directly linked to a trip to Central or West Africa or to other people who have returned from a trip have been reported in many countries and the situation is therefore changing rapidly. In France, 4,982 cases of monkeypox have been identified to date. The significant and sudden increase from April 2022 in the number of autochthonous cases in several regions not endemic for MPXV and far away from each other, by human-to-human transmission, makes this virus an emerging biological pathogen. How does this infection present and how can we prevent it?
- monkeypox
- signs and symptoms
- disease transmission
- preventive care
- vaccination
- treatment
Publisher keywords: disease transmission, monkeypox, preventive care, signs and symptoms, treatment, vaccination